Clinical Trials Logo

Clinical Trial Summary

Fluid resuscitation is the most effective treatment of shock. Isotonic crystalloid solution is the current recommended initial fluid resuscitation. However, this kind of fluid has high volume of distribution and may require large volume administration before achieve therapeutic goal of shock reversal. There are rising concern about the delay in shock reversal and adverse consequences of large amount volume of fluid therapy. Colloid fluid have been used as the alternate fluid resuscitation, aiming to limit the volume of fluid resuscitation and promote shock reversal. Whether colloid infusion can improve shock reversal rate and decrease complication associated with fluid resuscitation, had inconclusive information.


Clinical Trial Description

Fluid resuscitation is the most effective treatment of shock. Isotonic crystalloid solution is the current recommended initial fluid resuscitation. However, this kind of fluid has high volume of distribution and may require large volume administration before achieve therapeutic goal of shock reversal. There are rising concern about the delay in shock reversal and adverse consequences of large amount volume of fluid therapy. Colloid fluid have been used as the alternate fluid resuscitation, aiming to limit the volume of fluid resuscitation and promote shock reversal. Data from a recent randomized controlled study showed the improve long term survival among shock patients whose resuscitated with colloid solution. There were evidence about the increase incidence of acute kidney injury among critically ill patients who received hydroxyethyl starch, a previously worldwide used colloid solution. For septic shock, the leading cause of shock in current situation, resuscitation with albumin may associated with better outcome, while increasing mortality had been reported among the patient who received hydroxyethyl starch. Whether colloid infusion can improve shock reversal rate and decrease complication associated with fluid resuscitation, had inconclusive information. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02782819
Study type Interventional
Source Mahidol University
Contact Surat Tongyoo, MD.
Phone +6624198534
Email surat_Ty@yahoo.co.uk
Status Recruiting
Phase N/A
Start date September 2014
Completion date November 2018

See also
  Status Clinical Trial Phase
Completed NCT06121115 - Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit
Terminated NCT04538079 - Non-invasive Objective Assessment of Hemodynamics in Preterm Neonates
Completed NCT03701646 - ClearSight Validation in Pediatrics
Completed NCT02070276 - Predict Fluid Responsiveness in Spinal Anesthesia N/A
Completed NCT04891380 - BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study N/A
Completed NCT03927066 - Physiological Validation of Current Machine Learning Models for Hemodynamic Instability in Humans N/A
Recruiting NCT04760977 - Prehospital Management of Hypotensive Trauma in HEMS
Completed NCT03582501 - Measurement of Hemodynamic Responses to Lower Body Negative Pressure N/A
Terminated NCT03407287 - Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status
Active, not recruiting NCT04688450 - BP Management System User Acceptance Testing N/A
Terminated NCT03214809 - The Use of a Point-of-care Thoracic Ultrasound Protocol for Hospital Medical Emergency Teams N/A
Not yet recruiting NCT03671070 - Role of Low Dose Epinephrine Boluses In Acute Hypotension N/A
Completed NCT04497155 - Prehospital Norepinephrine and Early Mortality in Traumatic Shock
Completed NCT04269382 - Accuracy of Non-Invasive Blood Pressure Measurements at the Arm, Calf , and Finger N/A
Recruiting NCT05931601 - Early Initiated Vasopressor Therapy in the Emergency Department Phase 3
Recruiting NCT05355974 - Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure Phase 3
Completed NCT04529005 - Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients Phase 4